Loading company…
Philadelphia-based provider of Concentriq digital pathology software for life sciences organizations and diagnostic labs.
Founded in 2014 in Philadelphia, US, Proscia Inc. delivers digital pathology solutions through its Concentriq platform, including Concentriq AP, Concentriq AP-Dx and Concentriq LS, for life sciences organizations and diagnostic laboratories. Concentriq AP-Dx is FDA-cleared for primary diagnosis. David West is CEO, and founders include Coleman Stavish and Nathan Buchbinder. In March 2025 the company raised USD 35.003 mn in Series B funding led by Insight Partners, across 7 deals in total.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in